Page last updated: 2024-09-05

cgp 54626 and 3,4-dihydroxyphenylglycol

cgp 54626 has been researched along with 3,4-dihydroxyphenylglycol in 1 studies

Compound Research Comparison

Studies
(cgp 54626)
Trials
(cgp 54626)
Recent Studies (post-2010)
(cgp 54626)
Studies
(3,4-dihydroxyphenylglycol)
Trials
(3,4-dihydroxyphenylglycol)
Recent Studies (post-2010) (3,4-dihydroxyphenylglycol)
5701693255191

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernier, BE; Clements, MA; Morikawa, H; Perra, S1

Other Studies

1 other study(ies) available for cgp 54626 and 3,4-dihydroxyphenylglycol

ArticleYear
In vivo ethanol experience increases D(2) autoinhibition in the ventral tegmental area.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011, Volume: 36, Issue:5

    Topics: Action Potentials; Analysis of Variance; Animals; Baclofen; Central Nervous System Depressants; Chelating Agents; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Electric Stimulation; Enzyme Inhibitors; Estrenes; Ethanol; GABA Antagonists; GABA-B Receptor Agonists; In Vitro Techniques; Indoles; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Neural Inhibition; Neurons; Organophosphorus Compounds; Patch-Clamp Techniques; Pyrrolidinones; Receptors, Dopamine D2; Time Factors; Ventral Tegmental Area

2011